Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 2880K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Gavert, N. Articles by Ben-Ze'ev, A. Search for Related Content PubMed PubMed Citation Articles by Gavert, N. Articles by Ben-Ze'ev, A. Related Collections Related Article Social Bookmarking                            What's this?

L1, a novel target of ß-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers

¹ Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel
² Tumor Immunology Programme, D010 German Cancer Research Center, D-69120, Heidelberg, Germany
³ Department of Pathology, University of Erlangen-Nürnberg, 91054 Erlangen, Germany

Correspondence to Avri Ben-Ze'ev: avri.ben-zeev{at}weizmann.ac.il

Aberrant ß-catenin-TCF target gene activation plays a key role in colorectal cancer, both in the initiation stage and during invasion and metastasis. We identified the neuronal cell adhesion molecule L1, as a target gene of ß-catenin-TCF signaling in colorectal cancer cells. L1 expression was high in sparse cultures and coregulated with ADAM10, a metalloprotease involved in cleaving and shedding L1's extracellular domain. L1 expression conferred increased cell motility, growth in low serum, transformation and tumorigenesis, whereas its suppression in colon cancer cells decreased motility. L1 was exclusively localized in the invasive front of human colorectal tumors together with ADAM10. The transmembrane localization and shedding of L1 by metalloproteases could be useful for detection and as target for colon cancer therapy.

Abbreviations used in this paper: NLEF, dominant negative LEF-1; NTCF; dominant negative TCF.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related Article

Another job for ß-catenin

Rabiya S. Tuma
J. Cell Biol. 2005 168: 521. [Full Text] [PDF]

This article has been cited by other articles:

• KODERA, Y., NAKANISHI, H., ITO, S., MISAWA, K., ITO, Y., NAKAYAMA, G., KOIKE, M., FUJIWARA, M., YAMAMURA, Y., NAKAO, A. (2009). Expression of L1 Cell Adhesion Molecule Is a Significant Prognostic Factor in pT3-stage Gastric Cancer. Anticancer Res 29: 4033-4039 [Abstract] [Full Text]  
• Geismann, C., Morscheck, M., Koch, D., Bergmann, F., Ungefroren, H., Arlt, A., Tsao, M.-S., Bachem, M. G., Altevogt, P., Sipos, B., Folsch, U. R., Schafer, H., Muerkoster, S. S. (2009). Up-regulation of L1CAM in Pancreatic Duct Cells Is Transforming Growth Factor {beta}1- and Slug-Dependent: Role in Malignant Transformation of Pancreatic Cancer. Cancer Res. 69: 4517-4526 [Abstract] [Full Text]  
• Jang, Y.-N., Jung, Y.-S., Lee, S. H., Moon, C.-H., Kim, C.-H., Baik, E. J. (2009). Calpain-Mediated N-Cadherin Proteolytic Processing in Brain Injury. J. Neurosci. 29: 5974-5984 [Abstract] [Full Text]  
• Maddaluno, L., Verbrugge, S. E., Martinoli, C., Matteoli, G., Chiavelli, A., Zeng, Y., Williams, E. D., Rescigno, M., Cavallaro, U. (2009). The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells. JEM 206: 623-635 [Abstract] [Full Text]  
• Gu, W., Wells, A. L., Pan, F., Singer, R. H. (2008). Feedback Regulation between Zipcode Binding Protein 1 and {beta}-Catenin mRNAs in Breast Cancer Cells. Mol. Cell. Biol. 28: 4963-4974 [Abstract] [Full Text]  
• James, S. E., Greenberg, P. D., Jensen, M. C., Lin, Y., Wang, J., Till, B. G., Raubitschek, A. A., Forman, S. J., Press, O. W. (2008). Antigen Sensitivity of CD22-Specific Chimeric TCR Is Modulated by Target Epitope Distance from the Cell Membrane. J. Immunol. 180: 7028-7038 [Abstract] [Full Text]  
• Zecchini, S., Bianchi, M., Colombo, N., Fasani, R., Goisis, G., Casadio, C., Viale, G., Liu, J., Herlyn, M., Godwin, A. K., Nuciforo, P. G., Cavallaro, U. (2008). The Differential Role of L1 in Ovarian Carcinoma and Normal Ovarian Surface Epithelium. Cancer Res. 68: 1110-1118 [Abstract] [Full Text]  
• Gavert, N., Sheffer, M., Raveh, S., Spaderna, S., Shtutman, M., Brabletz, T., Barany, F., Paty, P., Notterman, D., Domany, E., Ben-Ze'ev, A. (2007). Expression of L1-CAM and ADAM10 in Human Colon Cancer Cells Induces Metastasis. Cancer Res. 67: 7703-7712 [Abstract] [Full Text]  
• Vignjevic, D., Schoumacher, M., Gavert, N., Janssen, K.-P., Jih, G., Lae, M., Louvard, D., Ben-Ze'ev, A., Robine, S. (2007). Fascin, a Novel Target of {beta}-Catenin-TCF Signaling, Is Expressed at the Invasive Front of Human Colon Cancer. Cancer Res. 67: 6844-6853 [Abstract] [Full Text]  
• Meng, Q., Rayala, S. K., Gururaj, A. E., Talukder, A. H., O'Malley, B. W., Kumar, R. (2007). Signaling-dependent and coordinated regulation of transcription, splicing, and translation resides in a single coregulator, PCBP1. Proc. Natl. Acad. Sci. USA 104: 5866-5871 [Abstract] [Full Text]  
• Demuth, T., Reavie, L. B., Rennert, J. L., Nakada, M., Nakada, S., Hoelzinger, D. B., Beaudry, C. E., Henrichs, A. N., Anderson, E. M., Berens, M. E. (2007). MAP-ing glioma invasion: Mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival. Molecular Cancer Therapeutics 6: 1212-1222 [Abstract] [Full Text]  
• Uchiyama, S, Itoh, H, Naganuma, S, Nagaike, K, Fukushima, T, Tanaka, H, Hamasuna, R, Chijiiwa, K, Kataoka, H (2007). Enhanced expression of hepatocyte growth factor activator inhibitor type 2-related small peptide at the invasive front of colon cancers. Gut 56: 215-226 [Abstract] [Full Text]  
• Knogler, K., Grunberg, J., Zimmermann, K., Cohrs, S., Honer, M., Ametamey, S., Altevogt, P., Fogel, M., Schubiger, P. A., Novak-Hofer, I. (2007). Copper-67 Radioimmunotherapy and Growth Inhibition by Anti-L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis. Clin. Cancer Res. 13: 603-611 [Abstract] [Full Text]  
• Shtutman, M., Levina, E., Ohouo, P., Baig, M., Roninson, I. B. (2006). Cell Adhesion Molecule L1 Disrupts E-Cadherin-Containing Adherens Junctions and Increases Scattering and Motility of MCF7 Breast Carcinoma Cells. Cancer Res. 66: 11370-11380 [Abstract] [Full Text]  
• Barbieri, C. E., Tang, L. J., Brown, K. A., Pietenpol, J. A. (2006). Loss of p63 Leads to Increased Cell Migration and Up-regulation of Genes Involved in Invasion and Metastasis.. Cancer Res. 66: 7589-7597 [Abstract] [Full Text]  
• Arlt, M. J.E., Novak-Hofer, I., Gast, D., Gschwend, V., Moldenhauer, G., Grunberg, J., Honer, M., Schubiger, P. A., Altevogt, P., Kruger, A. (2006). Efficient Inhibition of Intra-Peritoneal Tumor Growth and Dissemination of Human Ovarian Carcinoma Cells in Nude Mice by Anti-L1-Cell Adhesion Molecule Monoclonal Antibody Treatment. Cancer Res. 66: 936-943 [Abstract] [Full Text]  
• Conacci-Sorrell, M., Kaplan, A., Raveh, S., Gavert, N., Sakurai, T., Ben-Ze'ev, A. (2005). The Shed Ectodomain of Nr-CAM Stimulates Cell Proliferation and Motility, and Confers Cell Transformation. Cancer Res. 65: 11605-11612 [Abstract] [Full Text]  
• Maretzky, T., Schulte, M., Ludwig, A., Rose-John, S., Blobel, C., Hartmann, D., Altevogt, P., Saftig, P., Reiss, K. (2005). L1 Is Sequentially Processed by Two Differently Activated Metalloproteases and Presenilin/{gamma}-Secretase and Regulates Neural Cell Adhesion, Cell Migration, and Neurite Outgrowth. Mol. Cell. Biol. 25: 9040-9053 [Abstract] [Full Text]  
• Gavert, N., Conacci-Sorrell, M., Gast, D., Schneider, A., Altevogt, P., Brabletz, T., Ben-Ze'ev, A. (2005). L1, a novel target of {beta}-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. JEM 201: i7-7 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents